[go: up one dir, main page]

WO2010111264A3 - Préparations de rasagiline - Google Patents

Préparations de rasagiline Download PDF

Info

Publication number
WO2010111264A3
WO2010111264A3 PCT/US2010/028314 US2010028314W WO2010111264A3 WO 2010111264 A3 WO2010111264 A3 WO 2010111264A3 US 2010028314 W US2010028314 W US 2010028314W WO 2010111264 A3 WO2010111264 A3 WO 2010111264A3
Authority
WO
WIPO (PCT)
Prior art keywords
rasagiline
formulations
pharmaceutically acceptable
salt
aspects relate
Prior art date
Application number
PCT/US2010/028314
Other languages
English (en)
Other versions
WO2010111264A2 (fr
Inventor
Deepak Gupta
Nagesh Nagaraju
Sanjay Tripathi
M. Pavan Kumar
Shrikant Vitthalrao Dhoke
Suryakumar Jayanthi
Original Assignee
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of WO2010111264A2 publication Critical patent/WO2010111264A2/fr
Publication of WO2010111264A3 publication Critical patent/WO2010111264A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne des préparations pharmaceutiques comprenant de la rasagiline ou des sels pharmaceutiquement acceptables de celle-ci. Certains aspects de la présente invention concernent des préparations fabriquées en utilisant de la rasagiline ou un sel ayant une répartition de la taille des particules selon laquelle environ 90 % des particules ont une taille inférieure à 1 000 μm, et ayant une uniformité de teneur telle que la préparation contient entre 90 % et 110 % de la teneur de l'étiquette en rasagiline ou en ses sels. Selon d'autres aspects, la présente invention concerne des préparations pharmaceutiquement stables comprenant de la rasagiline ou un sel pharmaceutiquement acceptable et au moins un excipient pharmaceutiquement acceptable, les formulations étant sensiblement dépourvues de polyol.
PCT/US2010/028314 2009-03-24 2010-03-23 Préparations de rasagiline WO2010111264A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN658CH2009 2009-03-24
IN658/CHE/2009 2009-03-24
US18651809P 2009-06-12 2009-06-12
US61/186,518 2009-06-12

Publications (2)

Publication Number Publication Date
WO2010111264A2 WO2010111264A2 (fr) 2010-09-30
WO2010111264A3 true WO2010111264A3 (fr) 2011-02-24

Family

ID=42781817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/028314 WO2010111264A2 (fr) 2009-03-24 2010-03-23 Préparations de rasagiline

Country Status (1)

Country Link
WO (1) WO2010111264A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010274589A1 (en) * 2009-07-23 2012-02-16 Alkem Laboratories Ltd. Oral pharmaceutical composition of rasagiline and process for preparing thereof
EP2389927A1 (fr) * 2010-05-30 2011-11-30 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Formulations pharmaceutiques de rasagiline
EP2705021A2 (fr) 2011-05-04 2014-03-12 Cadila Healthcare Limited Rasagiline et ses sels pharmaceutiquement acceptables
DE102012000786A1 (de) * 2012-01-18 2013-07-18 Stada Arzneimittel Ag Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung, enthaltend den Wirkstoff Rasagilin
WO2013175493A1 (fr) 2012-04-09 2013-11-28 Cadila Healthcare Limited Compositions pharmaceutiques orales stables
WO2014192022A1 (fr) * 2013-05-20 2014-12-04 Cadila Healthcare Limited Compositions pharmaceutiques de rasagiline
EP3274348A4 (fr) * 2015-03-26 2018-08-22 Unichem Laboratories Limited Procédé de préparation de sel de potassium d'azilsartan médoxomil
US10292947B2 (en) 2016-03-26 2019-05-21 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for N-propargylamine derivative
CN114469902B (zh) * 2020-10-23 2024-10-29 上海上药中西制药有限公司 雷沙吉兰或其药用盐舌下膜剂及其制备方法、应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006014973A2 (fr) * 2004-07-26 2006-02-09 Teva Pharmaceutical Industries, Ltd. Dosages pharmaceutiques contenant de la rasagiline
WO2006057912A2 (fr) * 2004-11-24 2006-06-01 Teva Pharmaceutical Industries, Ltd. Compositions de rasagiline delitantes oralement
WO2006091657A1 (fr) * 2005-02-23 2006-08-31 Teva Pharmaceutical Industries, Ltd. Preparations de rasagiline presentant une uniformite de teneur amelioree

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006014973A2 (fr) * 2004-07-26 2006-02-09 Teva Pharmaceutical Industries, Ltd. Dosages pharmaceutiques contenant de la rasagiline
WO2006057912A2 (fr) * 2004-11-24 2006-06-01 Teva Pharmaceutical Industries, Ltd. Compositions de rasagiline delitantes oralement
WO2006091657A1 (fr) * 2005-02-23 2006-08-31 Teva Pharmaceutical Industries, Ltd. Preparations de rasagiline presentant une uniformite de teneur amelioree

Also Published As

Publication number Publication date
WO2010111264A2 (fr) 2010-09-30

Similar Documents

Publication Publication Date Title
WO2010111264A3 (fr) Préparations de rasagiline
WO2013130669A8 (fr) Composition pharmaceutique et son administration
WO2011106416A3 (fr) Formulations à l'épreuve d'un usage abusif
WO2009122301A3 (fr) Particules de mésylate de rasagiline et leur procédé de préparation
WO2009092129A8 (fr) Composition pharmaceutique de duloxétine à libération retardée
BR112013026363A2 (pt) nanossuspensões de fármaco criodessecadas
WO2011084593A3 (fr) Formulations empêchant un usage abusif
WO2011076749A3 (fr) Forme solide de dosage pharmaceutique
MX2011001782A (es) Composicion farmaceutica y su administracion.
NZ721952A (en) Delayed release compositions of linaclotide
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
IN2012DN03130A (fr)
HK1213174A1 (zh) 穩定的含水依那西普製劑
WO2009050726A3 (fr) Compositions et procédé pour une délivrance améliorée de bupropione
WO2010021607A3 (fr) Préparation pharmaceutique
UA103179C2 (ru) Фармацевтическая композиция, которая содержит эзетимиб
WO2011067667A3 (fr) Microcapsules de fexofénadine et compositions les contenant
WO2011143118A3 (fr) Formulations résistantes à l'alcool
MX2023006856A (es) Composiciones de polvo seco con estearato de magnesio.
WO2012035283A8 (fr) Composition pharmaceutique
WO2012087255A3 (fr) Formulations pharmaceutiques
HK1216839A1 (zh) 调整释放制剂
HK1209371A1 (en) Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same
WO2012085284A3 (fr) Formulations pharmaceutiques à charge médicamenteuse élevée comprenant de la dronédarone et des sels pharmaceutiquement acceptables de celles-ci
WO2011056785A3 (fr) Compositions de cellulose microcristalline et de phosphate de calcium utiles en tant qu'excipients pharmaceutiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10756713

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10756713

Country of ref document: EP

Kind code of ref document: A2